Schonfeld Strategic Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$300K	–	3366
2022 Q3	$300K	Sell	30,000 -28,477	-49%	-$283K	﹤0.01%	2081
2022 Q2	$578K	Buy	58,477 +41,125	+237%	+$406K	0.01%	1289
2022 Q1	$171K	Buy	17,352 +4,722	+37%	+$46.4K	﹤0.01%	2039
2021 Q4	$124K	Hold	12,630	–	–	﹤0.01%	1846
2021 Q3	$124K	Buy	12,630 +2,630	+26%	+$25.9K	﹤0.01%	1891
2021 Q2	$99K	Buy	+10,000	New	+$101K	﹤0.01%	1826

Schonfeld Strategic Advisors's LUXA Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 30,000 shares — an estimated $300K sold.

Schonfeld Strategic Advisors first reported a position in LUXA in Q2 2021 and held it in 6 quarters. The position peaked at $578K in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 30,000 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $300K.
Schonfeld Strategic Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
Schonfeld Strategic Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $578K in Q2 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.